Cumberland Pharmaceuticals (CPIX) Misses Q4 EPS by 13c

Cumberland Pharmaceuticals (NASDAQ: CPIX) reported Q4 EPS of ($0.13), $0.13 worse than the analyst estimate of $0.00. Revenue for the quarter came in at $8.3 million versus the consensus estimate of $9.19 million.

For earnings history and earnings-related data on Cumberland Pharmaceuticals (CPIX) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Ennis (EBF) Reports In-Line Q1 EPS
• AeroVironment restates quarterly financials, citing $89M goodwill error